May 22, 2026
Biotechnology’s New Frontier: NSCEB Showcases Huntsville’s Role in National Security and Agricultural Resilience biotechnologys-new-frontier-nsceb-showcases-huntsvilles-role-in-national-security-and-agricultural-resilience

Biotechnology’s New Frontier: NSCEB Showcases Huntsville’s Role in National Security and Agricultural Resilience

Siti Muinah May 8, 2026 0
HUNTSVILLE, ALABAMA – In a significant move to bridge the gap between cutting-edge laboratory research and national...
Read More Read more about Biotechnology’s New Frontier: NSCEB Showcases Huntsville’s Role in National Security and Agricultural Resilience
A Trojan Horse in the War on Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor Defenses a-trojan-horse-in-the-war-on-cancer-mount-sinai-scientists-redefine-immunotherapy-by-targeting-tumor-defenses

A Trojan Horse in the War on Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor Defenses

Nana May 8, 2026 0
NEW YORK, NY – January 22, 2024 – In a significant paradigm shift for cancer treatment, scientists...
Read More Read more about A Trojan Horse in the War on Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor Defenses
Bridging the Gap: Bionews Launches "The Rare Journey" to Revolutionize Patient Storytelling in Rare Disease Care bridging-the-gap-bionews-launches-the-rare-journey-to-revolutionize-patient-storytelling-in-rare-disease-care

Bridging the Gap: Bionews Launches "The Rare Journey" to Revolutionize Patient Storytelling in Rare Disease Care

Iffa Jayyana May 8, 2026 0
PENSACOLA, Florida — August 19, 2024 — For the millions of individuals navigating the labyrinthine world of...
Read More Read more about Bridging the Gap: Bionews Launches "The Rare Journey" to Revolutionize Patient Storytelling in Rare Disease Care
Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging rivannas-accuro-xv-secures-fda-clearance-a-new-frontier-in-point-of-care-musculoskeletal-imaging

Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging

Ammar Sabilarrohman May 8, 2026 0
In a major milestone for point-of-care diagnostics, Virginia-based medical technology innovator Rivanna has received US Food and...
Read More Read more about Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging
The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis the-silent-pandemic-global-progress-and-persistent-gaps-in-the-fight-against-viral-hepatitis

The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis

Ali Ikhwan May 8, 2026 0
By Global Health Correspondent Despite significant strides in medical innovation and public health policy, viral hepatitis remains...
Read More Read more about The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis

You may have missed

clinical-setback-biogen-and-denalis-parkinsons-drug-fails-key-phase-2b-trial

Clinical Setback: Biogen and Denali’s Parkinson’s Drug Fails Key Phase 2b Trial

Basiran May 22, 2026 0
the-future-of-global-health-navigating-the-crossroads-of-pepfar-and-the-u-s-hiv-aids-strategy

The Future of Global Health: Navigating the Crossroads of PEPFAR and the U.S. HIV/AIDS Strategy

Asro May 22, 2026 0
bridging-the-gap-in-metastatic-research-dr-kelly-shanahan-outlines-vision-for-2026-grant-cycle-and-3-75-million-fundraising-target

Bridging the Gap in Metastatic Research: Dr. Kelly Shanahan Outlines Vision for 2026 Grant Cycle and $3.75 Million Fundraising Target

Evan Lee Salim May 22, 2026 0
advocacy-in-action-a-presidents-dispatch-from-the-frontlines-of-metastatic-breast-cancer

Advocacy in Action: A President’s Dispatch from the Frontlines of Metastatic Breast Cancer

Nana Muazin May 22, 2026 0